Concurrently, Fitch affirmed its WellSpan Health’s series 2014A and series 2008A, affecting approximately $216 million of debt.
The assignment and affirmation are a result of several factors, including WellSpan Health’s dominant market position, expanding regional presence, favorable leverage ratios and sufficient cash flow. Fitch also acknowledged the health system’s softened operating performance in 2017 as a result of a recent EHR implementation and high reliance on governmental payers.
The outlook is stable.
More articles on healthcare finance:
The impact of hurricanes, the revenue loss, the tough leadership decisions: 5 questions with Schneider Regional Medical Center CFO Scott Nothnagel
California hospital imposes overtime restrictions, hiring freeze to shore up finances
Why this $15M gift to an LA hospital is so unusual
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
